Stock Comparison
ABBV vs PFE
AbbVie Inc and Pfizer Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$151.09B
P/E (TTM)
70.3
34.9
Forward P/E
17.7
9.0
Price/Sales
6.8
2.4
Price/Book
51.1
1.8
EV/EBITDA
25.8
15.1
Dividend Yield
2.03%
4.81%
Profitability
Net Margin
9.82%
11.83%
Operating Margin
29.77%
23.45%
Return on Equity
62.30%
5.01%
Return on Assets
10.50%
5.78%
Growth (YoY)
Revenue Growth
10.20%
2.60%
Earnings Growth
290.40%
-10.10%
Price & Risk
Beta
0.3
0.3
52-Week High
$263.65
$28.08
52-Week Low
$197.38
$22.43
Analyst Target
$274.36
$28.63
Compare ABBV and PFE your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.